Achaogen
Shuang Wu began their professional career in 2012 as an Immunologist at UCSF. In 2015, they joined Achaogen as a Scientist and Senior Research Associate II. At Achaogen, their focus was on therapeutic antibody discovery, including mouse or human Single B cell cloning, antibody repertoire analysis, recombinant mAb expression, and mAb specificity/function testing.
Shuang Wu completed a Bachelor's Degree in life science at Nankai University from 2001 to 2005. shuang then went on to pursue a Doctor of Philosophy (Ph.D.) in Cell/Cellular and Molecular Biology at the Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences from 2005 to 2012.
This person is not in any teams
This person is not in any offices
Achaogen
Achaogen is a late-stage biopharmaceutical company passionately committed to the discovery, development, and commercialization of innovative antibacterial treatments against multi-drug resistant (MDR), gram-negative infections. We are anchored by our key values of integrity, accountability, transparency, scientific rigor and drive. We pride ourselves in creating a work community that is scientifically driven, supportive, and collaborative. We encourage the diversity of thought that leads to great innovation and are looking to add to our dynamic team with people who are driven to transform the lives of patients.